Table 6 The major Pseudomonas aeruginosa resistance rate (%) during 2022Q1 to 2023Q2
2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | |
|---|---|---|---|---|---|---|
Ciprofloxacin | 6 | 9.7 | 17.2 | 4.7 | 9.1 | 8.9 |
Gentamicin | 0 | 12.9 | 14.1 | 11.9 | 3.6 | 4.4 |
Ticarcillin | 16.1 | 9.1 | 14.6 | 0 | 18.2 | 5.3 |
Levofloxacin | 8 | 12.9 | 20.3 | 7.7 | 10.9 | 17.8 |